Already a DIA Member? Sign in. Not a member? Join.

Iniciar sesión

¿Ha olvidado su ID de usuario? or ¿Ha olvidado su contraseña?

Not a Member?

Create Account and Join

Ottawa Marriott Hotel

16 oct 2017 7:00 a.m. - 16 oct 2017 5:00 p.m.

100 Kent Street , Ottawa, ON K1P5R7 , CANADA

Canadian Pharmacovigilance and Risk Management Strategies Conference

Session 1: What’s New and What’s Hot in Pharmacovigilance

Session Chair(s)

Marc  Poitras, PhD, MBA

Marc Poitras, PhD, MBA

Scientific Manager, Marketed Pharmaceuticals and Medical Devices Bureau

Health Canada, Canada

In this session, you will learn about new/ongoing initiatives to strengthen postmarket surveillance activities. Representatives from Regulatory Agencies and industry will describe and discuss the progress of the implementation and the challenges anticipated and encountered. You will learn, among other things, how leveraging pharmacovigilance databases could facilitate the detection, assessment and confirmation of safety signals.

Speaker(s)

Melissa  Hunt, MSc

Modernizing Pharmacovigilance in Canada

Melissa Hunt, MSc

Health Canada, Canada

Director

Stella  Blackburn, MD, MA, MSc, FFPM, FISPE, FRCP

Real World Evidence: How Can We Use It Effectively to Inform Decision-Making

Stella Blackburn, MD, MA, MSc, FFPM, FISPE, FRCP

Consultant, United Kingdom

Strategy

Gerald  Dal Pan, MD, MHS

New Developments in Postmarketing Drug Safety

Gerald Dal Pan, MD, MHS

FDA, United States

Director, Office of Surveillance and Epidemiology, CDER

¿Tiene una cuenta?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.